HA
GILD icon

Herold Advisors’s Gilead Sciences GILD Stock Holding History

Herold Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839K Sell
6,624
-284
-4% -$37.4K 0.17% 135
2026
Q1 		$963K Sell
6,908
-178
-3% -$24.9K 0.21% 109
2025
Q4 		$870K Buy
7,086
+296
+4% +$36K 0.19% 116
2025
Q3 		$754K Sell
6,790
-623
-8% -$70.8K 0.17% 136
2025
Q2 		$822K Buy
7,413
+228
+3% +$24.3K 0.17% 132
2025
Q1 		$805K Sell
7,185
-560
-7% -$57.8K 0.18% 133
2024
Q4 		$715K Buy
7,745
+29
+0.4% +$2.61K 0.16% 148
2024
Q3 		$647K Buy
7,716
+474
+7% +$36.2K 0.14% 161
2024
Q2 		$497K Buy
7,242
+155
+2% +$10.3K 0.11% 181
2024
Q1 		$519K Sell
7,087
-201
-3% -$15.5K 0.13% 173
2023
Q4 		$591K Sell
7,288
-1,033
-12% -$80.4K 0.16% 144
2023
Q3 		$624K Buy
8,321
+2,016
+32% +$155K 0.19% 135
2023
Q2 		$486K Sell
6,305
-107
-2% -$8.53K 0.15% 154
2023
Q1 		$532K Buy
6,412
+348
+6% +$28.8K 0.18% 132
2022
Q4 		$521K Buy
6,064
+5
+0.1% +$396 0.22% 109
2022
Q3 		$373K Buy
6,059
+1,293
+27% +$81.5K 0.18% 133
2022
Q2 		$294K Buy
4,766
+106
+2% +$6.56K 0.13% 157
2022
Q1 		$277K Buy
4,660
+703
+18% +$44.9K 0.1% 170
2021
Q4 		$287K Buy
3,957
+203
+5% +$14K 0.11% 167
2021
Q3 		$262K Buy
+3,754
New +$264K 0.1% 168

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Herold Advisors's GILD Position: Q2 2026 in Review

Herold Advisors reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $37.4K and leaving 6,624 shares worth $839K. The position accounts for 0.17% of the portfolio, ranked #135.

Herold Advisors first reported a position in GILD in Q3 2021 and has held it in 20 quarters since. The position peaked at $963K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Herold Advisors held 6,624 shares of Gilead Sciences worth $839K as of Q2 2026.
  • Herold Advisors sold 284 Gilead Sciences shares in Q2 2026, an estimated $37.4K.
  • Gilead Sciences made up 0.17% of Herold Advisors's portfolio in Q2 2026, its #135 holding.
  • Herold Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 20 quarters since.
  • Herold Advisors's Gilead Sciences position peaked at $963K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Herold Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.